|
| Scientific Program |
| |
|
| Scientific Program | Search Abstract |
| |
|
|
| Session |
| |
| Non-Hodgkin lymphoma - Clinical I |
| Date: |
Friday, 05 June 2009
|
| Time: | 17:45-19:00 |
| Room: | |
| |
| 17:45-19:00 |
|
QUALITATIVE AND QUANTITATIVE ASSESSMENT OF BONE MARROW INVOLVEMENT IN THE ENTIRE SPECTRUM OF NON-HODGKIN’S LYMPHOMAS: COMPARISON BETWEEN HISTOLOGY AND FLOW CYTOMETRY IN 572 PATIENTS
| 0401 |
| Merli, Michele,
Arcaini, Luca,
Boveri, Emanuela,
Rattotti, Sara,
Picone, Cristina,
Passamonti, Francesco,
Vanelli, Laura,
Tenore, Annamaria,
Varettoni, Marzia,
Rizzi, Silvia,
Brusamolino, Ercole,
Rumi, Elisa,
Burroni, Barbara,
Pascutto, Cristiana,
Paulli, Marco,
Lazzarino, Mario
(Pavia, Italy) |
| |
| 17:45-19:00 |
|
CLIPI: A NEW PROGNOSTIC INDEX FOR INDOLENT CUTANEOUS B-CELL LYMPHOMA PROPOSED BY THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG 11)
| 0402 |
| Mian, Michael,
Cortelazzo, S.,
Federico, Massimo,
Luminari, Stefano,
Marcheselli, Luigi,
Cantonetti, Maria,
Sarris, Andreas,
Rossi, Andrea,
Rambaldi, Alessandro,
Lombardo, Giuseppe,
Frontoni, Marina,
Pasini, Felice,
Devizzi, Liliana,
Bairey, Osnat,
Busetto, Mario,
Berti, Emilio,
Martinelli, Giovanni,
Tsang, Richard,
Rudoy, Silvia,
Blum, Robert,
Ferreri, Andrés,
Pinotti, Graziella,
Pogliani, Enrico,
Zucca, Emanuele
(Bolzano, Italy) |
| |
| 17:45-19:00 |
|
RITUXIMAB-CHOP (R-CHOP) IN THE TREATMENT OF 441 DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) PATIENTS: OUTCOME AND PROGNOSTIC FACTORS FOCUSING TO THE REVISED INTERNATIONAL PROGNOSTIC INDEX (R-IPI)
| 0403 |
| Vassilakopoulos, Theodoros,
Pangalis, Gerassimos,
Anastasopoulou, Amalia,
Angelopoulou, Maria,
Dimou, Maria,
Stavroulaki, Emily,
Karakatsanis, Sotirios,
Kalpadakis, Christina,
Sachanas, Sotirios,
Kyrtsonis, Marie-Christine,
Kokoris, Stylianis,
Siakantaris, Marina,
Yiakoumis, Xanthi,
Roussou, Paraskevi,
Panayiotidis, Panayiotis,
Papadaki, Helen,
Constantinou, Nikolaos
(Athens, Greece) |
| |
| 17:45-19:00 |
|
FINAL RESULTS OF THE PHASE II MULTICENTER ITALIAN STUDY OF IMMUNOCHEMOTHERAPY WITH FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB (FCR) FOR SYMPTOMATIC WALDENSTROM’S MACROGLOBULINEMIA
| 0404 |
| Tedeschi, Alessandra,
Benevolo, G,
Varettoni , M,
Battista, M,
Visco , C,
Miqueleiz, S,
Ricci, F,
Zinzani, PL,
Meneghini, V,
Pioltelli, P,
Zaja, F,
Nichelatti, M,
Lazzarino, M,
Vitolo, U,
Morra, E
(Milano, Italy) |
| |
| 17:45-19:00 |
|
LNH-PRO-05 STUDY: EXCELLENT CLINICAL AND MOLECULAR RESPONSES IN FLIPI=2 FOLLICULAR LYMPHOMA PATIENTS WITH RITUXIMAB PLUS CVP (BAGLEY) AND 12 WEEKS OF INTERFERON ALFA
| 0405 |
| CANNATA-ORTIZ, JIMENA,
Nicolás, C.,
Garcia-Noblejas, A.,
Montes-Moreno, S.,
López, J.,
Requena, MJ.,
Piris, MA.,
Arranz, R.
(MADRID, Spain) |
| |
| 17:45-19:00 |
|
POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD): CHARACTERISTICS AND OUTCOME IN A BELGIAN UNIVERSITY HOSPITAL
| 0406 |
| Dierickx, Daan,
Tousseyn, Thomas,
De Wolf-Peeters, Christiane,
Delforge, Michel,
Devos, Timothy,
Janssens, Ann,
Maertens, Johan,
Meers, Stef,
Verhoef, Gregor
(Leuven, Belgium) |
| |
| 17:45-19:00 |
|
SAFETY AND CLINICAL ACTIVITY OF THE ANTI-CD22 IMMUNOCONJUGATE INOTUZUMAB OZOGAMICIN (CMC-544) IN COMBINATION WITH RITUXIMAB IN RECURRENT/REFRACTORY FOLLICULAR LYMPHOMA OR DIFFUSE LARGE B-CELL LYMPHOMA
| 0407 |
| Johnson, Peter,
Fayad, Luis,
Coiffier, Bertrand,
Smith, Mitchell,
Rohatiner, Ama,
Hess, Georg,
Kaufman, Jonathan,
Verhoef, Gregor,
Offner, Fritz,
Hua, Steven,
Patel, Hemant,
Vandendries, Erik,
Dang, Nam
(Southampton, United Kingdom) |
| |
| 17:45-19:00 |
|
CLINICAL SIGNIFICANCE OF THE PRESENCE OF OCCULT CNS INVOLVEMENT ASSESSED BY FLOW CYTOMETRY IN PATIENTS WITH NON HODGKIN’S LYMPHOMA AT HIGH RISK OF CNS RELAPSE
| 0408 |
| Sancho, Juan-Manuel,
Orfao, A,
Quijano, S,
Garcia, O,
Panizo, C,
Pérez-Ceballos, E,
Deben, G,
Salar, A,
González-Barca, E,
Alonso, N,
García-Vela, JA,
Capote, J,
Peñalver, FJ,
Provencio, M,
Arias, J,
Plaza, J,
Caballero, D,
Morado, M,
Cruz, M,
Palacios, A,
Carmona, A,
Conde, E,
Molero, T,
Romero, E,
Mateos, MC,
Peñarrubia, MJ,
Ribera, JM
(Badalona, Spain) |
| |
| 17:45-19:00 |
|
A PHASE 2 STUDY OF VORINOSTAT (SUBEROYLANILIDE HYDROXAMIC ACID, SAHA) IN RELAPSED OR REFRACTORY INDOLENT NON-HODGKIN’S LYMPHOMA. A CALIFORNIA CANCER CONSORTIUM STUDY
| 0409 |
| Kirschbaum, Mark,
Popplewell, Leslie,
Nademanee, Auyaporn,
Pullarkat, Vinod,
Delioukina, Maria,
Zain, Jasmine,
Matsuoka, Deron,
Pulone, Bernadette,
Frankel, Paul,
Forman, Stephen,
Espinoza-Delgado, Igor,
Newman, Edward
(Duarte, United States of America) |
| |
| 17:45-19:00 |
|
EARLY EVALUATION OF 18-FDG-POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY (PET) DOES NOT PREDICT THE OUTCOME IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) PATIENTS TREATED WITH R-CHOP
| 0410 |
| Pregno, Patrizia,
Chiappella, Annalisa,
Bellò, Marilena,
Ferrero, Simone,
Passera, Roberto,
Boccomini, Carola,
Botto, Barbara,
Castellano, Giancarlo,
Frairia, Chiara,
Franceschetti, Silvia,
Freilone, Roberto,
Menga, Massimo,
Salvi, Flavia,
Ladetto, Marco,
Vitolo, Umberto
(Turin, Italy) |
| |
| 17:45-19:00 |
|
ACTIVITY AND SAFETY OF BORTEZOMIB AND RITUXIMAB IN RELAPSED/REFRACTORY INDOLENT NON FOLLICULAR AND MANTLE-CELL NON HODGKIN LYMPHOMA: A PHASE II MULTICENTER STUDY BY INTERGRUPPO ITALIANO LINFOMI
| 0411 |
| Pregno, Patrizia,
Chiappella, Annalisa,
Zinzani, Pier Luigi,
Orsucci, Lorella,
Stefoni, Vittorio,
Russo, Eleonora,
Tucci, Alessandra,
Franceschetti, Silvia,
Freilone, Roberto,
Fabbri, Alberto,
Ferreri, Andres,
Gargantini, Livio,
Liberati, Anna Marina,
Rigacci, Luigi,
Evangelista, Andrea,
Vitolo, Umberto
(Turin, Italy) |
| |
| 17:45-19:00 |
|
LYMPHOMA – EMERGING REALITIES IN SUB-SAHARA AFRICA
| 0412 |
| Sissolak, Gerhard,
Juritz, June,
Sissolak, Dagmar,
Wood, Lucille,
Jacobs, Peter
(Cape Town, South Africa) |
| |
| 17:45-19:00 |
|
FIRST RESULTS OF LONG TERM RITUXIMAB MAINTENANCE TREATMENT IN FOLLICULAR LYMPHOMA: SAFETY ANALYSIS OF THE RANDOMIZED PHASE III TRIAL SAKK 35/03
| 0413 |
| Hitz, Felicitas,
Bassi, Simona,
Taverna, Christian,
Mingrone, Walter,
Pabst, Thomas,
Cevreska, Lidija,
Del Giglio, Auro,
Vorobiof, Daniel,
Simcock, Mathew,
Ghielmini, Michele
(St. Gallen, Switzerland) |
| |
| 17:45-19:00 |
|
VALIDATION OF ABSOLUTE LYMPHOCYTE COUNT / REVISED IPI (ALC/R-IPI) SCORE MODEL, AS A PROGNOSTIC INDEX FOR DIFFUSE LARGE-B-CELL LYMPHOMA IN RITUXIMAB ERA
| 0414 |
| Mendicino, Francesco,
Marcheselli, Luigi MS,
Bari, Alessia MD,
Marcheselli, Raffaella MS,
Falorio, Simona MD,
Polimeno, Giuseppe,
Cox, Maria Christina MD
(Rome, Italy) |
| |
| 17:45-19:00 |
|
SPLENECTOMY VERSUS RITUXIMAB IN THE TREATMENT OF SPLENIC MARGINAL ZONE LYMPHOMA (SMZL)
| 0415 |
| Kalpadakis, Christina,
Pangalis, Gerassimos,
Vassilakopoulos, Theodoros,
Sachanas, Sotirios,
Kyrtsonis, Marie-Christine,
Dimopoulou, Maria,
Korkolopoulou, Penelope,
Kontopidou, Flora,
Yiakoumis, Xanthi,
Siakantaris, Marina,
Dimitriadou, Evangelia,
Panayiotidis, Panayiotis,
Papadaki, Helen,
Angelopoulou, Maria
(Athens, Greece) |
| |
| 17:45-19:00 |
|
PHASE II STUDY OF INTRATHECAL LONG ACTING LIPOSOMAL CYTARABINE (DEPOCYTE®) IN THE PROPHYLAXIS OF LYMPHOMATOUS MENINGITIS IN HIV-RELATED NON-HODGKIN'S LYMPHOMA
| 0416 |
| Spina, Michele,
Chimienti, Emanuela,
Martellotta, Ferdinando,
Berretta, Massimiliano,
Zanet, Ernesto,
Nigri, Paola Katiuscia,
Canzonieri, Vincenzo,
Bulian, Pietro,
Tirelli, Umberto
(Aviano, Italy) |
| |
| 17:45-19:00 |
|
INTEREST OF 18-FLUORO-DEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (FDG-PET) IN INITIAL STAGING, RESPONSE ASSESSMENT AND PROGNOSTIC VALUE OF MANTLE CELL LYMPHOMA (MCL)
| 0417 |
| Touzeau, Cyrille,
Bodet-Milin, C,
Leux, C,
Mehmet, S,
Moreau, A,
Maisonneuve, H,
Morineau, N,
Jardel, H,
Moreau, P,
Gressin, R,
Harousseau, JL,
Moreau, P,
Kraeber-Bodere, F,
Le Gouill, S
(Nantes, France) |
| |
| 17:45-19:00 |
|
LONG-TERM FOLLOW-UP OF RITUXIMAB AND INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE (CDE) IN COMBINATION WITH HAART IN HIV-RELATED NON-HODGKIN'S LYMPHOMAS (NHL)
| 0418 |
| Spina, Michele,
Chimienti, Emanuela,
Vaccher, Emanuela,
Jaeger, Ulrich,
Sparano, Joseph,
Talamini, Renato,
Tirelli, Umberto
(Aviano, Italy) |
| |
|